Aims: To determine if leucocyte volume distribution analysis (LVDA), obtained using a Coulter Counter Model S Plus IV, can be used to aid differentiation of chronic lymphoproliferative disorder (CLPD) subtypes. Methods: Mean lymphocyte volume and lymphocyte distribution width were measured on each patient (n = 90) using a hard copy of an amplified LVDA histogram. The mean lymphocyte volume was taken as the mean of the values on either side of the peak at half maximum height. The lymphocyte distribution width was taken as the range of cell values between the two values used to calibrate the mean lymphocyte volume. A template showing typical histograms from commonly occurring CLPD was also produced on an acetate sheet. This was used to examine the histogram from each new patient to evaluate its usefulness as an alternative to the calculation of mean lymphocyte volume and lymphocyte distribution width. Results: Mean lymphocyte volume and lymphocyte distribution width were significantly higher in B cell lymphocytic leukaemia of mixed cell type (B CLLIPL), B cell non-Hodgkin's lymphoma with peripheral blood spill, hairy cell leukaemia and T cell prolymphocytic leukaemia than in B cell chronic lymphocytic leukaemia (B CLL). The mean lymphocyte volume, but not the lymphocyte distribution width, was also significantly higher in T cell chronic lymphocytic leukaemia than in B CLL. The template gave an immediate preliminary indication ofpossible subtype(s) of disorder and could be used as an alternative to measurement of mean lymphocyte volume and lymphocyte distribution width.
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Conclusions: Electronic haematology analysers producing an LVDA provide a useful, cost effective cell sizing analysis which can aid the differentiation of subtypes of CLPD. (7 Clin Pathol 1992; 45:875-879) The primary basis for differential diagnosis of chronic lymphoid leukaemias has traditionally been the morphology of the cells in peripheral blood and bone marrow smears. The availability of a wide spectrum of cytochemical and immunological markers, supplemented by electron microscopy, cytogenetic studies, and histological examination of biopsied lymph nodes and spleen, has helped elucidate the heterogenous nature of these leukaemias. The crucial role of immunophenotyping and electron microscopy is recognised in the recent French American British (FAB) proposals for the classification of the chronic lymphoid leukaemias,' but these techniques may not all be available in some centres.
The certain morphological identification of subtypes in the FAB classification can be difficult, especially if peripheral blood or bone marrow smears are not well spread and the leukaemic cells are present in small numbers. The identification of small numbers of prolymphocytes in the peripheral blood of a patient with T helper prolymphocytic leukaemia (T-PLL), who had been successfully treated with deoxycoformycin2 and who had begun to relapse, was in our experience difficult, even with the availability of a wide spectrum of cell markers.
Cell volume studies have been used by various workers to study leukaemic cells. 3 very wide white cell count range in the patients studied (counts up to 735 x 109/l), blood was diluted in Isoton III where necessary. This produced white cell counts in the range [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] x 109/1 for analysis on each patient, which avoided possible right-shifted histograms due to coincidence counts in patients with high white cell counts. Blood samples from patients with white cell counts of less than 20 x 109/l were processed without prior dilution.
Mean lymphocyte volumes (MLV) were measured using the method described by , Bessman and Johnson," based on a Gaussian ,um3 distribution of red blood cells. The cell volume at half maximum on either side of the peak was determined as the precise peak was difficult to inular lym-locate due to rounding. The mean lymphocyte yndrome. In volume was then taken as the mean of these I on clinical, two values (fig 1) . Sezary syndrome (n = 1) (fig 3) with the template (fig 2) gave an immediate indication of the most probable lymphoproliferative disease subgroup involved. T PLL(D), hairy cell leukaemia (B), Sezary syndrome (E) were all clearly distinguishable from B CLL, while B PLL(G) gave a less pronounced but still obvious right-shifted plot. A case of common acute lymphoblastic leukaemia (cALL) (FAB LI) is included in fig 3 for comparison. Figure 4 illustrates the leucocyte volume histograms of a patient with T PLL (CD4 +) (A) in remission after treatment with deoxycoformycin and (B-F) during subsequent relapse. The group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from a routine full blood count carried out at diagnosis, using a Coulter Counter Model S Plus IV or similar instrument. The cell size distribution of the malignant lymphoid cells can be assessed by examining a hard copy of the LVDA histogram, most easily by using an acetate template containing typical white cell sizing histograms of various lymphoproliferative disorders. In the patients described this simple procedure allowed all other lymphoproliferative disorders studied to be differentiated from B CLL. This aspect would be particularly important in those laboratories investigating small numbers of these disorders or where immunophenotyping is not performed routinely, allowing samples which might otherwise have been accepted as typical B CLL to be referred to other centres for further investigation.
The wide spectrum of known CLPDs' and their varying responses to different forms of treatment make it imperative that correct classification is achieved. The cell sizing procedure described here is a simple and useful extension of existing technology, alerting to the presence of lymphoproliferative disease other than B CLL and indicating the necessity for further investigations. Whether the procedure can differentiate between individual non-B CLL disorders cannot be decided from the present study due to the small number of patients in some of the groups but the data so far suggest that this may be possible. If so, this additional parameter may prove a valuable tool in the differential diagnosis of these disorders.
Of further practical value is the ability to detect small numbers of leukaemic cells in the peripheral blood of a patient relapsing after remission. As shown in fig 4, A limitation of the method is the fact that the cell membrane is collapsed on to the nucleus before sizing, and thus results may be more representative of nuclear size than overall cell size. Robinson et al," whose study was confined to B cell lymphoproliferative disorders, measured the cross-sectional area of the cells after separation over Lymphoprep and fixation for electron microscopy. An IBAS 2 computed image analysis system was used for the morphometric analysis. Nevertheless, in the three disorders common to both studies (B CLL, B PLL, and hairy cell leukaemia) they found the same hierarchy of cell size, with hairy cell leukaemia cells being the largest followed by B P11 cells and B CLL cells. Thus while neither method is a true measure of overall cell volume, there is good correlation between these studies in those disorders common to both. Furthermore, using a Coulter Counter Model ZB1 linked to a Coulter Channeliser, Melo et al,'0 in a study of B CLL, B PLL, SLVL, hairy cell leukaemia and hairy cell leukaemia varient (HCLV) again found the same hierarchy of cell size, with HCLV, not included in the present study, occupying a position between SLVL and hairy cell leukaemia. However, unlike these other two studies, the method presented here does not require any specialised equipment.
The mean cell volume is one of the most reproducible full blood count parameters and cell sizing of leukaemic lymphoid cells seems to be similarly reproducible. The results described here were produced on a Coulter Counter Model S Plus IV, but other electronic cell counters producing a leucocyte volume distribution analysis should be similarly suitable for the procedure. While measurement of the mean lymphocyte volume and lymphocyte distribution width can be circumvented by use of a template as described in this study, the data to produce these parameters are accessible in the electronic cell counter, and instrument manufacturers may consider it appropriate that the lymphocyte equivalent of the mean cell volume and red cell distribution width be made available in future instruments.
